Price Alert

Citius Oncology Inc. (CTOR)

NASDAQ: CTOR · Real-Time Price · USD

1.61

-0.09 (-5.29%)

At close: Aug 20, 2025, 3:59 PM

1.63

1.24%

After-hours: Aug 20, 2025, 07:45 PM EDT

Citius Oncology Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q1 2023
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Dec 31, 2022
Net Income	-7.74K	-6.66M	n/a	252.46K	-4.83K	-4.73M	-5.19K	380.81K
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	2.09K	1.81M	n/a	n/a	1.96K	1.92M	1.97K	n/a
Other Working Capital	4.54K	8.54M	3.55K	17.5K	2.44K	3.75M	3.06K	60.79K
Other Non-Cash Items	2.07K	n/a	-1.29K	-634.02K	443.00	-218.19K	-105.36K	-486.99K
Deferred Income Tax	n/a	264.24K	n/a	n/a	n/a	144K	n/a	n/a
Change in Working Capital	3.58K	4.59M	1.42K	17.5K	2.44K	2.67M	3.06K	60.79K
Operating Cash Flow	n/a	n/a	126.35	-364.06K	n/a	-218.19K	-105.53K	-45.39K
Capital Expenditures	n/a	n/a	n/a	-4.46	n/a	n/a	-3.83	-1.01
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	-198.53K	n/a	-653.38K	-640.4K	-63.7M
Sales Maturities Of Investments	n/a	n/a	n/a	175.98K	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	-5K	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	-5K	-22.55K	n/a	-653.38K	-640.4K	-63.7M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	4.87K	353.65K	n/a	875.08K	411.18K	-363.21K
Financial Cash Flow	n/a	n/a	4.87K	353.65K	n/a	875.08K	411.18K	64.02M
Net Cash Flow	n/a	n/a	n/a	n/a	n/a	6.22K	-343.57K	n/a
Free Cash Flow	n/a	n/a	126.35	-364.06K	n/a	-218.19K	-105.53K	-45.39K